Question 1

Does Focus Partners Wealth own TXG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Focus Partners Wealth holds 214,296 shares of TXG (10x Genomics), worth $8.2M.

Question 2

How many shares of TXG does Focus Partners Wealth own?

Accepted Answer

As of its Q2 2026 13F, Focus Partners Wealth holds 214,296 shares of TXG (10x Genomics).

Question 3

What is Focus Partners Wealth's TXG position worth?

Accepted Answer

As of its Q2 2026 13F, Focus Partners Wealth's TXG position is worth $8.2M.

Question 4

Is Focus Partners Wealth buying or selling TXG?

Accepted Answer

In Q2 2026, Focus Partners Wealth reduced its TXG position by 10,200 shares (-4.5%).

Question 5

When did Focus Partners Wealth first buy TXG?

Accepted Answer

Focus Partners Wealth first reported TXG in its Q1 2025 13F and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	214,296	-4.5%	$8.2M	0.0%	$38.34	0
2026-Q1	Increased	224,496	+18.7%	$4.8M	0.0%	$21.23	32
2025-Q4	Increased	189,059	+334.4%	$3.1M	0.0%	$16.31	43
2025-Q3	Increased	43,523	+47.2%	$588,899	0.0%	$11.69	33
2025-Q2	Increased	29,569	+179.5%	$342,410	0.0%	$11.58	38
2025-Q1	New	10,578	—	$92,346	0.0%	$8.73	30